Development Level

Tbio 32 | 11,445
Tclin 6 | 613
Tchem 2 | 1,598

IMPC Phenotype

preweaning lethality, complete... 5 | 979
embryonic lethality prior to t... 4 | 278
embryonic lethality prior to o... 3 | 239
increased mean corpuscular vol... 3 | 92
abnormal eye morphology 2 | 68
abnormal humerus morphology 2 | 11
decreased erythrocyte cell num... 2 | 62
decreased mean corpuscular hem... 2 | 31
decreased mean corpuscular vol... 2 | 79
increased mean corpuscular hem... 2 | 96
abnormal coat-hair pigmentatio... 1 | 64
abnormal embryo size 1 | 220
abnormal femur morphology 1 | 14
abnormal gait 1 | 69
abnormal incisor color 1 | 3
abnormal lens morphology 1 | 81
abnormal pericardium morpholog... 1 | 26
abnormal spleen morphology 1 | 55
abnormal tibia morphology 1 | 14
abnormal tooth morphology 1 | 24
cataract 1 | 92
decreased body length 1 | 101
decreased body weight 1 | 161
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased circulating fructosa... 1 | 30
decreased circulating glucose ... 1 | 126
decreased circulating serum al... 1 | 82
decreased granulocyte number 1 | 6
decreased heart weight 1 | 27
decreased lean body mass 1 | 135
decreased startle reflex 1 | 75
enlarged heart 1 | 210
enlarged lymph nodes 1 | 37
enlarged uterus 1 | 11
hydrometra 1 | 53
impaired righting response 1 | 26
increased heart weight 1 | 62
increased lymphocyte cell numb... 1 | 32
increased monocyte cell number 1 | 63
increased neutrophil cell numb... 1 | 46
short tibia 1 | 97
small superior vagus ganglion 1 | 74
thrombocytosis 1 | 27

Disease

Cancer 24 | 2,499
Carcinoma 24 | 11,493
ovarian cancer 24 | 8,520
glioblastoma 20 | 5,792
lung cancer 20 | 4,740
atypical teratoid / rhabdoid tumor 18 | 5,112
osteosarcoma 17 | 7,950
psoriasis 17 | 6,694
interstitial cystitis 16 | 2,312
Autosomal recessive predisposition 15 | 1,442
Breast cancer 15 | 3,578
ependymoma 15 | 4,679
medulloblastoma, large-cell 15 | 6,241
pancreatic cancer 15 | 2,398
adrenocortical carcinoma 13 | 1,428
malignant mesothelioma 13 | 3,232
breast carcinoma 12 | 1,638
diabetes mellitus 12 | 1,728
intraductal papillary-mucinous neoplasm (IPMN) 12 | 3,291
invasive ductal carcinoma 12 | 2,951
Astrocytoma, Pilocytic 11 | 3,081
intraductal papillary-mucinous adenoma (IPMA) 11 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 11 | 2,989
Muscle hypotonia 10 | 571
Prostatic Neoplasms 10 | 495
Schizophrenia 10 | 1,160
adult high grade glioma 10 | 3,801
cystic fibrosis 10 | 1,696
ductal carcinoma in situ 10 | 1,745
lung adenocarcinoma 10 | 2,716
lung carcinoma 10 | 2,843
non-small cell lung cancer 10 | 2,890
Big calvaria 9 | 147
Hypertension 9 | 396
Increased head circumference 9 | 147
Increased size of cranium 9 | 147
Increased size of skull 9 | 147
Kidney cancer 9 | 2,613
Liver Cirrhosis, Experimental 9 | 769
colon cancer 9 | 1,478
group 4 medulloblastoma 9 | 1,855
oligodendroglioma 9 | 2,850
subependymal giant cell astrocytoma 9 | 2,287
Seizures 8 | 596
active ulcerative colitis 8 | 764
pituitary cancer 8 | 1,972
tuberculosis 8 | 2,010
Carcinoma, Hepatocellular 7 | 228
Duchenne muscular dystrophy 7 | 601
Dysarthria 7 | 192
Epilepsy 7 | 792
Hypertensive disease 7 | 292
Liver carcinoma 7 | 240
Obesity 7 | 678
Vascular disease 7 | 319
esophageal adenocarcinoma 7 | 737
fibroadenoma 7 | 559
juvenile dermatomyositis 7 | 1,187
nasopharyngeal carcinoma 7 | 1,058
ulcerative colitis 7 | 1,819
Atopic dermatitis 6 | 952
Becker muscular dystrophy 6 | 191
Leukodystrophy 6 | 55
Major Depressive Disorder 6 | 301
Multiple myeloma 6 | 1,332
Muscle Spasticity 6 | 195
Optic Atrophy 6 | 242
Osteoporosis 6 | 363
Pulmonary Fibrosis 6 | 106
Short stature 6 | 531
Unipolar Depression 6 | 250
active Crohn's disease 6 | 922
acute myeloid leukemia 6 | 783
acute quadriplegic myopathy 6 | 1,158
astrocytic glioma 6 | 2,597
astrocytoma 6 | 1,146
autosomal dominant Emery-Dreifuss muscular dystrophy 6 | 510
gastric carcinoma 6 | 807
limb girdle muscular dystrophy 2A 6 | 213
pancreatic ductal adenocarcinoma liver metastasis 6 | 1,962
primary pancreatic ductal adenocarcinoma 6 | 1,109
primitive neuroectodermal tumor 6 | 3,035
Adenocarcinoma of lung 5 | 142
Arthritis 5 | 290
Developmental regression 5 | 95
Endometriosis 5 | 540
Heart disease 5 | 306
Liver Cirrhosis 5 | 181
Loss of developmental milestones 5 | 95
Lung Neoplasms 5 | 232
Mental deterioration in childhood 5 | 95
Neurodevelopmental regression 5 | 95
Personality change 5 | 23
Psychomotor regression 5 | 95
Psychomotor regression beginning in infancy 5 | 95
Psychomotor regression in infants 5 | 95
Psychomotor regression, progressive 5 | 95
Secondary physiologic amenorrhea 5 | 32
cutaneous lupus erythematosus 5 | 1,057
spina bifida 5 | 1,074

Tissue

Endocrine System 40 | 18,159
Female tissues 40 | 17,400
Blood and immune system 39 | 16,909
Digestive Tract 39 | 17,369
Liver and Pancreas 39 | 16,750
Male tissues 39 | 17,142
Respiratory system 39 | 16,393
Urinary Tract 39 | 16,678
Nervous System 37 | 16,725
Skin and soft tissues 37 | 17,230
Cardiovascular System 34 | 15,192

Target Family

Non-IDG 26 | 12,091
Enzyme 7 | 4,145
Transcription Factor 3 | 1,400
Kinase 2 | 634
GPCR 1 | 408
Ion Channel 1 | 344

GO Process

response to peptide hormone 40 | 40
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Protein BTG2 BTG2 Tbio Non-IDG -2.10376 142.7 209
Translation initiation factor eIF-2B subunit delta EIF2B4 Tbio Non-IDG -1.06082 11.3 145
Stanniocalcin-2 STC2 Tbio Non-IDG -1.78204 65.8 317
Low-density lipoprotein receptor-related protein 5 LRP5 Tbio Non-IDG -3.10429 1247.5 302
Stromal cell-derived factor 1 CXCL12 Tbio Non-IDG -3.48446 3085.9 607
Transient receptor potential cation channel subfamily V member 1 TRPV1 Tclin Ion Channel -3.26780 1774.6 373
Dystroglycan DAG1 Tbio Enzyme -2.77503 560.0 254
Hematopoietically-expressed homeobox protein HHEX HHEX Tbio Transcription Factor -3.05655 1150.7 363
Translation initiation factor eIF-2B subunit gamma EIF2B3 Tbio Non-IDG -1.21999 16.3 170
Trefoil factor 1 TFF1 Tbio Non-IDG -2.40517 263.2 481